Arbutus Biopharma Corp (NASDAQ:ABUS)

2.50
Delayed Data
As of Aug 12
 +0.03 / +1.21%
Today’s Change
1.93
Today|||52-Week Range
6.50
-35.73%
Year-to-Date

Today’s Trading

Previous close2.47
Today’s open2.46
Day’s range2.46 - 2.54
Volume23,044
Average volume (3 months)1,084,364
Market cap$374.9M
Data as of 3:59pm ET, 08/12/2022

Growth & Valuation

Earnings growth (last year)+16.84%
Earnings growth (this year)+45.06%
Earnings growth (next 5 years)+3.00%
Revenue growth (last year)+58.92%
P/E ratioNM
Price/Sales37.61
Price/Book2.14

Competitors

----
--Cassiopea SpA0.000.00%
EYPTEyePoint Pharmaceuti...-0.07-0.63%
STROSutro Biopharma Inc+0.29+4.26%
Data as of 3:59pm ET, 08/12/2022

Financials

Next reporting dateNovember 9, 2022
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$11.0M
Annual profit (last year)-$76.2M
Net profit margin-693.91%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Warminster, Pennsylvania

Forecasts